Associated Papers
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants.
Feng S et al.
Nature Immunology, 2025
39930093 (PubMed )
Supplement: 41590_2025_2088_MOESM3_ESM.xlsx › Table_1
Diagnosis traps for patients with acquired NLRP3 mutation.
Cescato M et al.
European Journal of Internal Medicine, 2024
Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin-Associated Periodic Syndromes With Hearing Loss as the Primary Presentation, Responsive to Anti-Interleukin-1 Therapy.
Birk-Bachar M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2024
HSP90β controls NLRP3 autoactivation.
Spel L et al.
Science Advances, 2024
38416826 (PubMed )
Supplement: sciadv.adj6289_sm.pdf
The phenotype and genotype of Chinese adult patients with NLRP3-associated autoinflammatory disease.
Wu N et al.
Clinical Rheumatology, 2023
Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis.
Graustein AD et al.
American Journal of Respiratory Cell and Molecular Biology, 2021
Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature.
Yokoi K et al.
Pediatric Rheumatology Online Journal, 2021
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy.
Vitale A et al.
Internal and Emergency Medicine, 2017
Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study.
Naselli A et al.
The Journal of Rheumatology, 2016
Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
Sarrabay G et al.
Expert Review of Clinical Immunology, 2015
Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.
Lasigliè D et al.
Plos One, 2011
Select a paper to view details